MedPath

The physiological role of bile acid‐mediated glucagon‐like peptide‐1 release in humans: The Cerebrotendinous Xanthomatosis Mixed Meal Test study.

Conditions
diabetes, insulin resistance
Registration Number
NL-OMON23193
Lead Sponsor
AMC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

Inclusion criteria, CTX patients:

1. Adult age (older than 18 years of age);

Exclusion Criteria

Since CTX is a rare disorder, little exclusion criteria exist. However, patients that use medication that interferes with glucose metabolism such as oral antidiabetic medication or
insulin are not included.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glucose, bile acids and incretins during meal test.
Secondary Outcome Measures
NameTimeMethod
Energy expenditure.
© Copyright 2025. All Rights Reserved by MedPath